The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
First clinical-grade porcine kidney xenotransplant using a human decedent model
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Elimination of growth hormone receptor gene expression could reduce organ sizes but comes with other undesired biological consequences.
“Although elimination of growth hormone receptor gene expression could reduce organ sizes2,3, it comes with other undesired biological consequences7.”
From Design and testing of a humanized porcine donor for xenotransplantation (2023) · cites this paper as [2]
Section 2.3.1 reports that growth hormone receptor knockout was accompanied by reduced serum IGF-1 levels and body weight, establishing a biological effect beyond organ size. It does not characterize the lower IGF-1 level as undesired. The Discussion attributes altered renal structural integrity to the pigs’ genetic modifications collectively, not specifically to growth hormone receptor knockout. (LLM, conf=0.75)
Experimental — accuracy not yet measuredXenotransplantation may offer a transformative solution to the worldwide organ shortage crisis.
“Xenotransplantation may offer a transformative solution to the worldwide organ shortage crisis1–3.”
From Design and testing of a humanized porcine donor for xenotransplantation (2023) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transplanting organs from pigs to humans
Sykes, M., & Sachs, D. H. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau6298 · Cited by 191
Flagged first, then by citations
Research works printed but not linked: 31
- Wolfe, 1999, Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med., 341, 1725, 10.1056/NEJM199912023412303 · DOI
- Goldberg, 2017, Trial of Transplantation of HCV-infected kidneys into uninfected recipients, N Engl J Med., 376, 2394, 10.1056/NEJMc1705221 · DOI
- Montgomery, 2011, Desensitization in HLA-incompatible kidney recipients and survival, N Engl J Med., 365, 318, 10.1056/NEJMoa1012376 · DOI
- Starzl, 1964, Renal heterotransplantation from baboon to man: experience with 6 cases, Transplantation., 2, 752, 10.1097/00007890-196411000-00009 · DOI
- Kuwaki, 2005, Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience, Nat Med., 11, 29, 10.1038/nm1171 · DOI
- Phelps, 2003, Production of alpha 1,3-galactosyltransferase-deficient pigs, Science., 299, 411, 10.1126/science.1078942 · DOI
- Yamada, 2005, Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue, Nat Med., 11, 32, 10.1038/nm1172 · DOI
- Cooper, 2019, Justification of specific genetic modifications in pigs for clinical organ xenotransplantation, Xenotransplantation., 26, e12516, 10.1111/xen.12516 · DOI
- Niu, 2017, Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9, Science., 357, 1303, 10.1126/science.aan4187 · DOI · Paper page
- Yang, 2015, Genome-wide inactivation of porcine endogenous retroviruses (PERVs), Science., 350, 1101, 10.1126/science.aad1191 · DOI
- Parent, 2020, The ethics of testing and research of manufactured organs on brain-dead/recently deceased subjects, J Med Ethics., 46, 199, 10.1136/medethics-2019-105674 · DOI
- Wood, 2004, Care of the potential organ donor, N Engl J Med., 351, 2730, 10.1056/NEJMra013103 · DOI
- Yamamoto, 2019, Life-supporting kidney xenotransplantation from genetically engineered pigs in baboons: a comparison of two immunosuppressive regimens, Transplantation., 103, 2090, 10.1097/TP.0000000000002796 · DOI
- Díaz Varela, 2003, Cross-reactivity between swine leukocyte antigen and human anti-HLA-specific antibodies in sensitized patients awaiting renal transplantation, J Am Soc Nephrol., 14, 2677, 10.1097/01.ASN.0000088723.07259.CF · DOI
- Taylor, 1998, HLA-specific antibodies in highly sensitized patients can cause a positive crossmatch against pig lymphocytes, Transplantation., 65, 1634, 10.1097/00007890-199806270-00016 · DOI
- Martens, 2017, Humoral reactivity of renal transplant-waitlisted patients to cells from GGTA1/CMAH/B4GalNT2, and SLA class I knockout pigs, Transplantation., 101, e86, 10.1097/TP.0000000000001646 · DOI
- Ladowski, 2018, Swine leukocyte antigen class II is a xenoantigen, Transplantation., 102, 249, 10.1097/TP.0000000000001924 · DOI
- Lunney, 2009, Molecular genetics of the swine major histocompatibility complex, the SLA complex, Dev Comp Immunol., 33, 362, 10.1016/j.dci.2008.07.002 · DOI
- Smith, 2005, Nomenclature for factors of the SLA class-I system, 2004, Tissue Antigens., 65, 136, 10.1111/j.1399-0039.2005.00337.x · DOI
- Smith, 2005, Nomenclature for factors of the swine leukocyte antigen class II system, 2005, Tissue Antigens., 66, 623, 10.1111/j.1399-0039.2005.00492.x · DOI
- Kaulitz, 2011, Development of sensitive methods for detection of porcine endogenous retrovirus-C (PERV-C) in the genome of pigs, J Virol Methods., 175, 60, 10.1016/j.jviromet.2011.04.017 · DOI
- Kono, 2020, A highly sensitive method for the detection of recombinant PERV-A/C env RNA using next generation sequencing technologies, Sci Rep., 10, 21935, 10.1038/s41598-020-78890-2 · DOI
- Wynyard, 2014, Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand, Xenotransplantation., 21, 309, 10.1111/xen.12102 · DOI
- Matsumoto, 2020, Long-term follow-up for the microbiological safety of clinical microencapsulated neonatal porcine islet transplantation, Xenotransplantation., 27, e12631, 10.1111/xen.12631 · DOI
- Denner, 2018, Why was PERV not transmitted during preclinical and clinical xenotransplantation trials and after inoculation of animals?, Retrovirology., 15, 28, 10.1186/s12977-018-0411-8 · DOI
- Poppelaars, 2017, Complement-mediated inflammation and injury in brain dead organ donors, Mol Immunol., 84, 77, 10.1016/j.molimm.2016.11.004 · DOI
- Shimizu, 2012, Pathologic characteristics of transplanted kidney xenografts, J Am Soc Nephrol., 23, 225, 10.1681/ASN.2011040429 · DOI
- Hillmen, 2006, The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria, N Engl J Med., 355, 1233, 10.1056/NEJMoa061648 · DOI
- Locke, 2009, The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection, Am J Transplant., 9, 231, 10.1111/j.1600-6143.2008.02451.x · DOI
- Orandi, 2014, Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation, Transplantation., 98, 857, 10.1097/TP.0000000000000298 · DOI
- Adams, 2021, Anti-C5 antibody tesidolumab reduces early antibody-mediated rejection and prolongs survival in renal xenotransplantation, Ann Surg., 274, 473, 10.1097/SLA.0000000000004996 · DOI · Paper page
Cited by
Sorted by citations
Design and testing of a humanized porcine donor for xenotransplantation
Anand, R. P., Layer, J. V., Heja, D., Hirose, T., Lassiter, G., Firl, D. J., Paragas, V. B., Akkad, A., Chhangawala, S., Colvin, R. B., et al. (2023) · Nature · doi:10.1038/s41586-023-06594-4 · Cited by 302
Metadata
- Authors
- Porrett, P. M., Orandi, B. J., Kumar, V., Houp, J., Anderson, D., Cozette Killian, A., Hauptfeld-Dolejsek, V., Martin, D. E., Macedon, S., Budd, N., Stegner, K. L., Dandro, A., Kokkinaki, M., Kuravi, K. V., Reed, R. D., Fatima, H., Killian, J. T., Baker, G., Perry, J., Wright, E. D., Cheung, M. D., Erman, E. N., Kraebber, K., Gamblin, T., Guy, L., George, J. F., Ayares, D., & Locke, J. E.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 22
- Issue
- 4
- Pages
- 1037-1053
- ISSN
- 1600-6135
- Cited by
- 417
- References
- 1
- Language
- en
- Licence
- Funders
- United Therapeutics Corporation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review